Alligator Bioscience AB (publ) (STO:ATORX)
0.2044
-0.0056 (-2.67%)
Feb 11, 2026, 9:28 AM CET
Alligator Bioscience AB Market Cap
Alligator Bioscience AB has a market cap or net worth of 112.25 million as of February 10, 2026. Its market cap has decreased by -11.63% in one year.
Market Cap
112.25M
Enterprise Value
124.38M
Revenue
46.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.20
Market Cap Chart
Since November 23, 2016, Alligator Bioscience AB's market cap has decreased from 2.67B to 112.25M, a decrease of -95.79%. That is a compound annual growth rate of -29.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 112.25M | 660.45% |
| Dec 30, 2025 | 14.76M | -92.20% |
| Dec 30, 2024 | 189.17M | -58.27% |
| Dec 29, 2023 | 453.33M | 32.59% |
| Dec 30, 2022 | 341.91M | -39.69% |
| Dec 30, 2021 | 566.90M | -0.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Isofol Medical AB | 168.52M |
| IRLAB Therapeutics AB | 142.36M |
| Biovica International AB | 129.61M |
| Simris Group AB (PUBL) | 126.32M |
| Annexin Pharmaceuticals AB | 112.24M |
| Biosergen AB | 106.61M |
| Active Biotech AB | 101.22M |
| Spago Nanomedical AB | 83.03M |